vs
AMN HEALTHCARE SERVICES INC（AMN）与Astrana Health, Inc.（ASTH）财务数据对比。点击上方公司名可切换其他公司
Astrana Health, Inc.的季度营收约是AMN HEALTHCARE SERVICES INC的1.3倍（$950.5M vs $748.2M），Astrana Health, Inc.净利率更高（0.7% vs -1.0%，领先1.7%），Astrana Health, Inc.同比增速更快（42.9% vs 1.8%），AMN HEALTHCARE SERVICES INC自由现金流更多（$67.6M vs $-6.0M），过去两年Astrana Health, Inc.的营收复合增速更高（53.3% vs -4.5%）
AMN医疗保健服务公司是美国领先的医疗人力资源解决方案提供商，主要为医院、诊所等各类医疗机构提供护士、医师、医技人员及其他临床、非临床岗位的临时与长期派遣服务，同时提供医护团队管理技术支持及相关咨询服务。
Astrana Health是一家总部位于美国的价值导向型医疗服务提供商，主要服务全美符合联邦医保资格的老年群体，提供上门初级护理、慢性病管理及护理协调服务，致力于提升患者健康水平、降低不必要的医疗支出。
AMN vs ASTH — 直观对比
营收规模更大
ASTH
是对方的1.3倍
$748.2M
营收增速更快
ASTH
高出41.1%
1.8%
净利率更高
ASTH
高出1.7%
-1.0%
自由现金流更多
AMN
多$73.6M
$-6.0M
两年增速更快
ASTH
近两年复合增速
-4.5%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $748.2M | $950.5M |
| 净利润 | $-7.7M | $6.6M |
| 毛利率 | 26.1% | — |
| 营业利润率 | 1.1% | 1.9% |
| 净利率 | -1.0% | 0.7% |
| 营收同比 | 1.8% | 42.9% |
| 净利润同比 | 95.9% | 184.4% |
| 每股收益（稀释后） | $-0.19 | $0.12 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AMNASTH
| Q4 25 | $748.2M | $950.5M | ||
| Q3 25 | $634.5M | $956.0M | ||
| Q2 25 | $658.2M | $654.8M | ||
| Q1 25 | $689.5M | $620.4M | ||
| Q4 24 | $734.7M | $665.2M | ||
| Q3 24 | $687.5M | $478.7M | ||
| Q2 24 | $740.7M | $486.3M | ||
| Q1 24 | $820.9M | $404.4M |
净利润AMNASTH
| Q4 25 | $-7.7M | $6.6M | ||
| Q3 25 | $29.3M | $373.0K | ||
| Q2 25 | $-116.2M | $9.4M | ||
| Q1 25 | $-1.1M | $6.7M | ||
| Q4 24 | $-187.5M | $-7.8M | ||
| Q3 24 | $7.0M | $16.1M | ||
| Q2 24 | $16.2M | $19.2M | ||
| Q1 24 | $17.3M | $14.8M |
毛利率AMNASTH
| Q4 25 | 26.1% | — | ||
| Q3 25 | 29.1% | — | ||
| Q2 25 | 29.8% | — | ||
| Q1 25 | 28.7% | — | ||
| Q4 24 | 29.8% | — | ||
| Q3 24 | 31.0% | — | ||
| Q2 24 | 31.0% | — | ||
| Q1 24 | 31.4% | — |
营业利润率AMNASTH
| Q4 25 | 1.1% | 1.9% | ||
| Q3 25 | 7.5% | 2.0% | ||
| Q2 25 | -18.8% | 3.1% | ||
| Q1 25 | 1.8% | 3.3% | ||
| Q4 24 | -27.6% | 0.1% | ||
| Q3 24 | 3.2% | 5.9% | ||
| Q2 24 | 5.1% | 6.2% | ||
| Q1 24 | 4.9% | 7.5% |
净利率AMNASTH
| Q4 25 | -1.0% | 0.7% | ||
| Q3 25 | 4.6% | 0.0% | ||
| Q2 25 | -17.7% | 1.4% | ||
| Q1 25 | -0.2% | 1.1% | ||
| Q4 24 | -25.5% | -1.2% | ||
| Q3 24 | 1.0% | 3.4% | ||
| Q2 24 | 2.2% | 3.9% | ||
| Q1 24 | 2.1% | 3.7% |
每股收益（稀释后）AMNASTH
| Q4 25 | $-0.19 | $0.12 | ||
| Q3 25 | $0.76 | $0.01 | ||
| Q2 25 | $-3.02 | $0.19 | ||
| Q1 25 | $-0.03 | $0.14 | ||
| Q4 24 | $-4.90 | $-0.14 | ||
| Q3 24 | $0.18 | $0.33 | ||
| Q2 24 | $0.42 | $0.40 | ||
| Q1 24 | $0.45 | $0.31 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $34.0M | $429.5M |
| 总债务越低越好 | $767.1M | — |
| 股东权益账面价值 | $642.1M | $779.3M |
| 总资产 | $2.1B | $2.2B |
| 负债/权益比越低杠杆越低 | 1.19× | — |
8季度趋势，按日历期对齐
现金及短期投资AMNASTH
| Q4 25 | $34.0M | $429.5M | ||
| Q3 25 | $52.6M | $463.4M | ||
| Q2 25 | $41.5M | $342.1M | ||
| Q1 25 | $55.8M | $260.9M | ||
| Q4 24 | $10.6M | $290.8M | ||
| Q3 24 | $30.6M | $350.3M | ||
| Q2 24 | $48.0M | $327.7M | ||
| Q1 24 | $50.6M | $337.3M |
总债务AMNASTH
| Q4 25 | $767.1M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $1.1B | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益AMNASTH
| Q4 25 | $642.1M | $779.3M | ||
| Q3 25 | $644.4M | $775.5M | ||
| Q2 25 | $607.6M | $765.5M | ||
| Q1 25 | $715.1M | $745.4M | ||
| Q4 24 | $706.6M | $712.7M | ||
| Q3 24 | $890.7M | $704.6M | ||
| Q2 24 | $876.9M | $678.9M | ||
| Q1 24 | $854.2M | $653.5M |
总资产AMNASTH
| Q4 25 | $2.1B | $2.2B | ||
| Q3 25 | $2.1B | $2.2B | ||
| Q2 25 | $2.2B | $1.4B | ||
| Q1 25 | $2.4B | $1.3B | ||
| Q4 24 | $2.4B | $1.4B | ||
| Q3 24 | $2.7B | $1.3B | ||
| Q2 24 | $2.8B | $1.3B | ||
| Q1 24 | $2.9B | $1.2B |
负债/权益比AMNASTH
| Q4 25 | 1.19× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 1.49× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $75.6M | $-2.9M |
| 自由现金流经营现金流 - 资本支出 | $67.6M | $-6.0M |
| 自由现金流率自由现金流/营收 | 9.0% | -0.6% |
| 资本支出强度资本支出/营收 | 1.1% | 0.3% |
| 现金转化率经营现金流/净利润 | — | -0.44× |
| 过去12个月自由现金流最近4个季度 | $233.8M | $104.5M |
8季度趋势，按日历期对齐
经营现金流AMNASTH
| Q4 25 | $75.6M | $-2.9M | ||
| Q3 25 | $22.7M | $10.0M | ||
| Q2 25 | $78.5M | $90.9M | ||
| Q1 25 | $92.7M | $16.6M | ||
| Q4 24 | $72.8M | $-10.9M | ||
| Q3 24 | $66.7M | $34.0M | ||
| Q2 24 | $99.5M | $23.2M | ||
| Q1 24 | $81.4M | $6.0M |
自由现金流AMNASTH
| Q4 25 | $67.6M | $-6.0M | ||
| Q3 25 | $14.8M | $7.4M | ||
| Q2 25 | $68.7M | $89.5M | ||
| Q1 25 | $82.7M | $13.6M | ||
| Q4 24 | $56.6M | $-13.5M | ||
| Q3 24 | $47.4M | $31.7M | ||
| Q2 24 | $72.2M | $20.4M | ||
| Q1 24 | $63.2M | $5.6M |
自由现金流率AMNASTH
| Q4 25 | 9.0% | -0.6% | ||
| Q3 25 | 2.3% | 0.8% | ||
| Q2 25 | 10.4% | 13.7% | ||
| Q1 25 | 12.0% | 2.2% | ||
| Q4 24 | 7.7% | -2.0% | ||
| Q3 24 | 6.9% | 6.6% | ||
| Q2 24 | 9.8% | 4.2% | ||
| Q1 24 | 7.7% | 1.4% |
资本支出强度AMNASTH
| Q4 25 | 1.1% | 0.3% | ||
| Q3 25 | 1.2% | 0.3% | ||
| Q2 25 | 1.5% | 0.2% | ||
| Q1 25 | 1.4% | 0.5% | ||
| Q4 24 | 2.2% | 0.4% | ||
| Q3 24 | 2.8% | 0.5% | ||
| Q2 24 | 3.7% | 0.6% | ||
| Q1 24 | 2.2% | 0.1% |
现金转化率AMNASTH
| Q4 25 | — | -0.44× | ||
| Q3 25 | 0.77× | 26.69× | ||
| Q2 25 | — | 9.65× | ||
| Q1 25 | — | 2.48× | ||
| Q4 24 | — | — | ||
| Q3 24 | 9.54× | 2.11× | ||
| Q2 24 | 6.13× | 1.21× | ||
| Q1 24 | 4.70× | 0.40× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AMN
| Travel Nurse Staffing | $208.3M | 28% |
| Allied Staffing | $146.9M | 20% |
| Labor Disruption Services | $124.3M | 17% |
| Technology And Workforce Solutions | $88.0M | 12% |
| Language Services | $69.9M | 9% |
| Other | $29.6M | 4% |
| International Nurse Staffing | $29.6M | 4% |
| Interim Leadership Staffing | $24.1M | 3% |
| Vendor Management Systems | $16.3M | 2% |
| Local Staffing | $8.6M | 1% |
| International Nurse Permanent Placement | $2.6M | 0% |
ASTH
| Medicare | $542.4M | 57% |
| Commercial | $99.1M | 10% |
| Care Delivery | $92.1M | 10% |
| Care Enablement | $78.9M | 8% |
| Other Third Parties | $58.0M | 6% |
| Health Care Patient Service | $39.8M | 4% |
| Health Care Other | $25.5M | 3% |
| Other | $12.1M | 1% |
| Management Service | $10.3M | 1% |
